NONMEM Users Network Archive

Hosted by Cognigen

Pharmacometrics summer internship at Boehringer Ingelheim US in 2020

From: julia.korell
Date: Fri, 18 Oct 2019 19:23:43 +0000

The BI Pharmacometrics Group in Ridgefield, CT is looking for a talented Ph=
D or MS student from the US to join us as intern over the summer in 2020.
This is an exciting opportunity to gain insight into pharmaceutical industr=
y and work on MID3 projects!

Benjamin Weber and I will be at ACoP next week and are happy to chat in per=
son if you are interested in this opportunity.

Boehringer Ingelheim is an equal opportunity global employer who takes prid=
e in maintaining a diverse and inclusive culture. We embrace diversity of p=
erspectives and strive for an inclusive environment which benefits our empl=
oyees, patients and communities.

Summer Intern - Pharmacometrics-1913946

Boehringer Ingelheim is currently seeking a talented and innovative Intern =
to join our Pharmacometrics Group located at our Ridgefield, CT facility. A=
s an Intern, you will you will be assigned to your own pharmacometrics proj=
ect and work under the supervision of an experienced pharmacometrician. The=
 project scope includes but is not limited to performing hands-on pharmacom=
etrics analysis in NONMEM and R based on pre-clinical and clinical pharmaco=
kinetic/pharmacodymanic data and collaborating with other stakeholders in d=
rug development. Ideally, the project results in a poster presentation or p=
As an employee of Boehringer Ingelheim, you will actively contribute to the=
 discovery, development and delivery of our products to our patients and cu=
stomers. Our global presence provides opportunity for all employees to coll=
aborate internationally, offering visibility and opportunity to directly co=
ntribute to the companies' success. We realize that our strength and compet=
itive advantage lie with our people. We support our employees in a number o=
f ways to foster a healthy working environment, meaningful work, diversity =
and inclusion, mobility, networking and work-life balance. Our competitive =
compensation and benefit programs reflect Boehringer Ingelheim's high regar=
d for our employees

Duties & Responsibilities:
Develop and qualify PK, PKPD and/or disease progression models including da=
ta set preparation and post-processing of software output
Perform literature research to support model development and qualification
Present project results and conclusions to Global Pharmacometrics Group and=
 other stakeholders
Summarize project results and conclusions in internal report and/or externa=
l poster/publication

Must be an Undergraduate, Graduate, or Professional Student in good academi=
c standing.
Must have completed 12 credit hours within a related major and/or other rel=
ated coursework.
Overall, cumulative GPA (from last completed quarter) must be at least 3.00=
0 (on 4.0 scale) or better (No rounding up).
Major must be related to the field of internship.

Desired Experience, Skills and Abilities:

  * Hands-on experience in pharmacometrics software packages (e.g., NONME=
M, R)
  * Basic knowledge in non-linear mixed effect modelling and biostatistic=
  * Basic knowledge in clinical pharmacology and model informed drug disc=
overy and development

Eligibility Requirements:
Must be legally authorized to work in the United States without restriction=
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older

Who We Are:
At Boehringer Ingelheim we create value through innovation with one clear g=
oal: to improve the lives of patients. We develop breakthrough therapies an=
d innovative healthcare solutions in areas of unmet medical need for both h=
umans and animals. As a family owned company we focus on long term performa=
nce. We are powered by 50.000 employees globally who nurture a diverse, col=
laborative and inclusive culture. Learning and development for all employee=
s is key because your growth is our growth. Want to learn more? Visit boe=<> and join us in =
our effort to make more health. Boehringer Ingelheim, including Boehringer=
 Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Inge=
lheim Animal Health USA, Inc., Merial Barceloneta, LLC and Boehringer Ingel=
heim Fremont, Inc. is an equal opportunity and affirmative action employer =
committed to a culturally diverse workforce. All qualified applicants will=
 receive consideration for employment without regard to race; color; creed;=
 religion; national origin; age; ancestry; nationality; marital, domestic p=
artnership or civil union status; sex, gender identity or expression; affec=
tional or sexual orientation; disability; veteran or military status, inclu=
ding protected veteran status; domestic violence victim status; atypical ce=
llular or blood trait; genetic information (including the refusal to submit=
 to genetic testing) or any other characteristic protected by law.
including protected veteran status; domestic violence victim status; atypic=
al cellular or blood trait; genetic information (including the refusal to s=
ubmit to genetic testing) or any other characteristic protected by law.

Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, produ=
ctive and efficient work environment for our employees, partners and custom=
ers. As part of that commitment, Boehringer Ingelheim conducts pre-employme=
nt verifications and drug screenings.

 - Apprenticeship/Internship
Primary Location
 - Americas-US-CT-Ridgefield
 - US-BI Pharma/BI USA
 - Full-time


Julia Korell, PhD
Director, Pharmacometrics
Translational Medicine & Clinical Pharmacology
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut
* +1 (203) 791-6794
+1 (203) 278-0683
* julia.korell>
[icon-twitter.gif]<> [icon-linkedin.gif] <http://linkd.=
in/LO4tAP> [icon-youtube.gif] <>

CONFIDENTIALITY NOTICE: This e-mail message, including any attachments, is =
for the sole use of the intended recipient(s) and may contain confidential =
and privileged information. Any unauthorized review, use, disclosure of dis=
tribution is prohibited. If you are not the intended recipient, please con=
tact sender by reply e-mail and destroy all copies of the original message.

(image/png attachment: image001.png)

(image/gif attachment: image002.gif)

(image/gif attachment: image003.gif)

(image/gif attachment: image004.gif)

Received on Fri Oct 18 2019 - 15:23:43 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: